Compare JAGX & CTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JAGX | CTNT |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9M | 4.0M |
| IPO Year | 2014 | 2023 |
| Metric | JAGX | CTNT |
|---|---|---|
| Price | $0.31 | $1.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $60.00 | N/A |
| AVG Volume (30 Days) | 247.4K | ★ 594.6K |
| Earning Date | 04-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.42 | 57.74 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,511,000.00 | $1,288,536.00 |
| Revenue This Year | $61.58 | $42.49 |
| Revenue Next Year | N/A | $22.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 182.69 |
| 52 Week Low | $0.22 | $0.02 |
| 52 Week High | $8.00 | $4.21 |
| Indicator | JAGX | CTNT |
|---|---|---|
| Relative Strength Index (RSI) | 16.97 | 24.93 |
| Support Level | $0.29 | $0.02 |
| Resistance Level | $0.46 | $1.53 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 1.27 | 20.00 |
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
Cheetah Net Supply Chain Service Inc is a provider of logistics and warehousing services, historically in connection with the sale of parallel-import vehicles sourced in the U.S. to be sold in the PRC market, and more recently for the transportation of other goods between the U.S. and the PRC. Parallel-import vehicles in the PRC refer to automobiles purchased directly from overseas markets and imported for sale outside of the brand manufacturer's official distribution networks. The company operates as single report segment. The company operates in the USA and overseas.